Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2502 (LINC02502)

Target
LINC02502
Molecular classification
Other, Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2502 (LINC02502) is a human long non-coding RNA gene that produces a lincRNA transcript not overlapping protein-coding genes[1][3]. LincRNAs, including LINC02502, are a subclass of non-coding RNAs longer than 200 nucleotides that function primarily in the regulation of gene expression, chromatin architecture, and transcriptional modulation, often acting as scaffolds for protein complexes or regulating the stability and translation of mRNA targets[5]. There is currently little direct evidence that LINC02502 itself is a validated therapeutic target, a biomarker, or has characterized disease associations, but lincRNAs as a group are increasingly recognized for roles in diverse biological processes and disease contexts, particularly cancer[5]. Specific functions, disease links, and therapeutic interactions for LINC02502 have not been established in major gene annotation or drug-target databases as of this time[1][3].

Other names
LINC02502
02

Biological functions

Regulation of gene expressionChromatin remodelingTranscriptional regulationRNA stabilizationScaffolding of protein complexesPotential enhancer-like activityOther
03

Disease associations

Cancer (suggested for broader lincRNA class)Other
04

Safety considerations

Not established

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2502 (LINC02502).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2502 (LINC02502).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call